Evidence map›Paper›PMID 27527584›Full record

ArticlePsychopharmacology2016

Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.

Isabella Canazza, Andrea Ossato, Claudio Trapella, Anna Fantinati, Maria Antonietta De Luca, Giulia Margiani, Fabrizio Vincenzi, Claudia Rimondo, Fabiana Di Rosa, Adolfo Gregori and 4 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Behavioral and Pharmacokinetics Studies ofInternational journal of molecular sciences · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Isabella CanazzaDepartment of Life Sciences and Biotechnology (SVeB), University of Ferrara, via Fossato di Mortara 17-19, 44121, Ferrara, Italy.
Andrea OssatoDepartment of Life Sciences and Biotechnology (SVeB), University of Ferrara, via Fossato di Mortara 17-19, 44121, Ferrara, Italy.
Claudio TrapellaDepartment of Chemistry and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Anna FantinatiDepartment of Chemistry and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Maria Antonietta De LucaDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Giulia MargianiDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Fabrizio VincenziDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.
Claudia RimondoDepartment of Diagnostic and Public Health, University of Verona, Verona, Italy.
Fabiana Di RosaDepartment of Scientific Investigation (RIS), Carabinieri, 00191, Rome, Italy.
Adolfo GregoriDepartment of Scientific Investigation (RIS), Carabinieri, 00191, Rome, Italy.
Katia VaraniDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.
Pier Andrea BoreaDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.
Giovanni SerpelloniU.R.I.To.N., Forensic Toxicology Unit, Department of Health Science, University of Florence, Florence, Italy.
Matteo MartiDepartment of Life Sciences and Biotechnology (SVeB), University of Ferrara, via Fossato di Mortara 17-19, 44121, Ferrara, Italy. m.marti@unife.it.
University of Ferrara · ITUniversity of Cagliari · ITUniversity of Florence · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleAKB48 and its fluorinate derivate 5F-AKB48 are two novel synthetic cannabinoids belonging to a structural class with an indazole core structure. They are marketed as incense, herbal preparations or chemical supply for their psychoactive Cannabis-like effects.

objectivesThe present study was aimed at investigating the in vitro and in vivo pharmacological activity of AKB48 and 5F-AKB48 in male CD-1 mice and comparing their in vivo effects with those caused by the administration of Δ

resultsIn vitro competition binding experiments performed on mouse and human CB

conclusionsFor the first time, the present study demonstrates the overall pharmacological effects induced by the administration of AKB48 and 5F-AKB48 in mice and suggests that the fluorination can increase the power and/or effectiveness of SCBs. Furthermore, this study outlines the potential detrimental effects of SCBs on human health.

Indexed as

AdamantaneAggressionAnimalsBehavior, AnimalBinding, CompetitiveCannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsCannabisCatalepsyDopamineDronabinolHumansIndazolesIndolesIn Vitro TechniquesMale1-pentyl-3-(1-naphthoyl)indoleAdamantaneAM 251Cannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsDopamineDronabinolIndazolesIndolesN-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamideN-(1-adamantyl)-1-pentylindazole-3-carboxamideNaphthalenesPiperidinesPyrazolesReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB25F-AKB48AKB48BehaviorCannabinoidsJWH-018MicrodialysisSensorimotor responsesSynthetic cannabinoidsΔ9-THC

Identifiers

PMID27527584
OpenAlexW2518658260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.